References
1) Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients
with variant angina and influential factors. Circulation 1988;78:1-9.
2) Mendelsohn ME, Karas RH.The protective effects of estrogen on the
cardiovascular system. N Engl J Med 1999;340:1801-1811.
3) Meyer MR, Barton M. ERalpha, ERbeta, and gpER: novel aspects of
oestrogen receptor signalling in atherosclerosis. Cardiovasc Res
2009;83:605-610.
4) Orshal JM, Khalil RA: Gender, sex hormones, and vascular tone. Am J
Physiol Regul Integr Comp Physiol 2004;286:R233-R249.
5) Nickenig G, Bäumer AT, Grohè C et al: Estrogen modulates AT1 receptor
gene expression in vitro and in vivo. Circulation1998;97:2197-2201.
6) Kawano H, Motoyama T, Ohgushi M et al: Menstrual cyclic variation of
myocardial ischemia in premenopausal women with variant angina. Ann
Intern Med 2001;135: 977-981.
7) Kazuko S,Takao K,Toshiyuki O : The epidemiological characteristics of
thromboembolism related to oral contraceptives in Japan: Results of a
national surgery 2021;47:198-207
8) Japanese Society of Obstetrics and Gynecology, ed. Low-Dose Oral
Contraceptives, Low Estrogen-Progestin Combination Drug Guide Line 2020
Edition
9) Trabert B, Sherman E, Kannnan N : Progesterone and Breast Cancer
2020, 41:320-344
10) Antunes CM, Strolley PD, Rosenshein NB et al : Endmetrial cancer and
estrogen use. Report of a large case-control study: N Engl J Med
1979,300:9-13
11) Guidelines for Diagnosis and Treatment of Patients with Vasospastic
Angina (Coronary Spastic Angina)JCS2013
12) Koshiba K, Hoka S. Clinical characteristics of perioperative
coronary spasm: reviews of 115 case reports in Japan. J Anesth.
2001;15(2):93–99.
13) Easley RB, Rosen RE, Lindeman KS. Coronary artery spasm during
initiation of epidural anesthesia. Anesthesiology. 2003;99(4):1015–7.